Correction to: Neuropsychopharmacology (2004) 29, 347–350. doi:10.1038/sj.npp.1300353
Following publication of the above paper, the author has identified an error with the legend for Figure 1. The legend should be read as follows:
Figure 1 Bispectral indices in the index patient (red line 0.3 mg etomidate/kg body weight) and a control (blue line, 0.25 mg etomidate/kg body weight). At time point 0 min, etomidate was administered. Horizontal bars indicate the time periods of loss of responsiveness of the index patient and the control to verbal commands. After loss of responsiveness to verbal commands, 0.75 mg succinylcholine/kg body weight was administered.
Additional information
The online version of the original article can be found at 10.1038/sj.npp.1300353
Rights and permissions
About this article
Cite this article
Kosel, M., Rudolph, U., Wielepp, P. et al. Erratum: Diminished GABAA Receptor Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety. Neuropsychopharmacol 29, 1762 (2004). https://doi.org/10.1038/sj.npp.1300448
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.npp.1300448